Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.4B | 1.9B | 2.2B | 2.0B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 781.0M | 792.6M | 719.3M | 758.7M |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 312.6M | 727.7M | 648.5M | 848.1M |
| Tax provision | -473.2K | 231.3M | 165.0M | 273.2M |
| Net income | 313.1M | 496.4M | 483.5M | 574.8M |
| Basic EPS | 0.3 | 0.4 | — | 0.5 |
| Diluted EPS | 0.3 | 0.4 | — | 0.5 |
| Basic average shares | 1.2B | 1.2B | — | 1.2B |
| Diluted average shares | 1.2B | 1.2B | — | 1.2B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 313.1M | 496.4M | 483.5M | 574.8M |
| Minority interests | -9.4M | -6.7M | -1.7M | -1.9M |
| Preferred stock dividends | — | — | — | — |